Literature DB >> 19213374

Frequency of endometriosis among infertile women and association of clinical signs and symptoms with the laparoscopic staging of endometriosis.

Urooj Bakht Khawaja1, Ameer Ali Khawaja, Saqib Ali Gowani, Sana Shoukat, Sana Ejaz, Farzana Nawaz Ali, Javaid Rizvi, Fauzia Haq Nawaz.   

Abstract

OBJECTIVE: The study aimed to determine the frequency of endometriosis in women who underwent diagnostic laparoscopy for evaluation of infertility and the association of clinical, ultrasonographic and laparoscopic findings of endometriosis with the laparoscopic stages of the disease.
METHOD: It was a retrospective study of women presenting to gynaecologic clinics of the Aga Khan University Hospital from January 1999 to December 2005 with primary complaint of primary or secondary infertility and were diagnosed with endometriosis through laparoscopy. Relevant demographic and clinical information was entered and analyzed in SPSS version 14.0.
RESULTS: The frequency of endometriosis in women with primary compliant of infertility was found to be 16.8%. Statistically significant associations was found between staging of the disease and thin built (p=0.007) and restricted uterine mobility on pelvic examination (p=0.035). The patients' ultrasound and laparoscopic examination showed significant association with staging of the disease with the presence of cysts on ultrasound (p-value < 0.0001) and adhesions on laparoscopy (p value <0.00001).
CONCLUSION: The variability of the definition and inconsistency in diagnostic methods makes the prevalence of endometriosis difficult to determine and we might underestimate the true burden of the disease. Most of the signs and symptoms of endometriosis do not correlate with the severity (staging) of the disease. Hence, Laparoscopy remains the gold standard for diagnosis as well as staging of endometriosis.

Entities:  

Mesh:

Year:  2009        PMID: 19213374

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  6 in total

1.  Myeloperoxidase as a Potential Target in Women With Endometriosis Undergoing IVF.

Authors:  Nalini Santanam; Nathaniel Zoneraich; Sampath Parthasarathy
Journal:  Reprod Sci       Date:  2016-09-27       Impact factor: 3.060

2.  Risk factors associated with endometriosis: importance of study population for characterizing disease in the ENDO Study.

Authors:  C Matthew Peterson; Erica B Johnstone; Ahmad O Hammoud; Joseph B Stanford; Michael W Varner; Anne Kennedy; Zhen Chen; Liping Sun; Victor Y Fujimoto; Mary L Hediger; Germaine M Buck Louis
Journal:  Am J Obstet Gynecol       Date:  2013-02-27       Impact factor: 8.661

3.  Occurrence of female genital tuberculosis among infertile women: a study from a tertiary maternal health care research centre in South India.

Authors:  V Bhanothu; J P Theophilus; P K Reddy; R Rozati
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-04       Impact factor: 3.267

4.  Relationship between the severity of endometriosis symptoms (dyspareunia, dysmenorrhea and chronic pelvic pain) and the spread of the disease on ultrasound.

Authors:  Elham Kor; Seyed Reza Saadat Mostafavi; Zahra Ahmadian Mazhin; Adeleh Dadkhah; Anis Kor; Shirin Habibi Arvanagh; Shima Ghafourian Noroozi; Ghazal Sadri
Journal:  BMC Res Notes       Date:  2020-11-25

Review 5.  The Role of Visceral Therapy in the Sexual Health of Women with Endometriosis during the COVID-19 Pandemic: A Literature Review.

Authors:  Tomasz Gozdziewicz; Grazyna Jarzabek-Bielecka; Dawid Luwanski; Malgorzata Wojcik; Katarzyna Plagens-Rotman; Malgorzata Mizgier; Magdalena Pisarska-Krawczyk; Witold Kedzia
Journal:  J Clin Med       Date:  2022-09-30       Impact factor: 4.964

6.  The Effect of Garlic Tablets on the Endometriosis-Related Pains: A Randomized Placebo-Controlled Clinical Trial.

Authors:  Sudabeh Amirsalari; Zahra Behboodi Moghadam; Ziba Taghizadeh; Mina Naghi Jafar Abadi; Parichehr Sabaghzadeh Irani; Saied Goodarzi; Hadi Ranjbar
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-20       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.